OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
4.490
+0.070 (1.58%)
Nov 21, 2024, 4:00 PM EST - Market closed
OptimizeRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 88.18 | 71.52 | 62.45 | 61.29 | 43.31 | 24.6 | Upgrade
|
| Revenue Growth (YoY) | 40.40% | 14.53% | 1.89% | 41.51% | 76.08% | 15.99% | Upgrade
|
| Cost of Revenue | 32.98 | 28.62 | 23.48 | 25.65 | 19.21 | 9.16 | Upgrade
|
| Gross Profit | 55.2 | 42.9 | 38.97 | 35.64 | 24.11 | 15.44 | Upgrade
|
| Selling, General & Admin | 44.81 | 40 | 33.49 | 27.7 | 20.18 | 14.58 | Upgrade
|
| Operating Expenses | 62.77 | 56.12 | 51.26 | 35.28 | 25.43 | 18.12 | Upgrade
|
| Operating Income | -7.57 | -13.22 | -12.29 | 0.36 | -1.32 | -2.69 | Upgrade
|
| Interest Expense | -6.05 | -1.45 | - | - | - | - | Upgrade
|
| Interest & Investment Income | 0.35 | 2.19 | 0.85 | 0.02 | 0.07 | 0.29 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.61 | 0.5 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -12.66 | -11.98 | -11.44 | 0.38 | -1.26 | -2.4 | Upgrade
|
| Merger & Restructuring Charges | -4.3 | -4.3 | - | - | -0.81 | -1.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.14 | -2.14 | - | - | - | - | Upgrade
|
| Asset Writedown | -6.74 | -6.74 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -0.14 | -0.64 | Upgrade
|
| Pretax Income | -33.33 | -25.16 | -11.44 | 0.38 | -2.21 | -4.04 | Upgrade
|
| Income Tax Expense | -9.16 | -7.6 | - | - | - | -0.9 | Upgrade
|
| Net Income | -24.17 | -17.57 | -11.44 | 0.38 | -2.21 | -3.14 | Upgrade
|
| Net Income to Common | -24.17 | -17.57 | -11.44 | 0.38 | -2.21 | -3.14 | Upgrade
|
| Shares Outstanding (Basic) | 18 | 17 | 18 | 17 | 15 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 17 | 18 | 18 | 15 | 13 | Upgrade
|
| Shares Change (YoY) | 6.86% | -3.71% | 0.53% | 19.31% | 10.76% | 12.85% | Upgrade
|
| EPS (Basic) | -1.33 | -1.03 | -0.64 | 0.02 | -0.15 | -0.23 | Upgrade
|
| EPS (Diluted) | -1.34 | -1.03 | -0.64 | 0.02 | -0.15 | -0.23 | Upgrade
|
| Free Cash Flow | -1.67 | -7.33 | 10.57 | 0.63 | -6.38 | -1.75 | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.43 | 0.59 | 0.04 | -0.43 | -0.13 | Upgrade
|
| Gross Margin | 62.59% | 59.98% | 62.40% | 58.14% | 55.65% | 62.77% | Upgrade
|
| Operating Margin | -8.59% | -18.49% | -19.68% | 0.59% | -3.06% | -10.92% | Upgrade
|
| Profit Margin | -27.41% | -24.56% | -18.32% | 0.62% | -5.10% | -12.78% | Upgrade
|
| Free Cash Flow Margin | -1.89% | -10.24% | 16.93% | 1.02% | -14.73% | -7.11% | Upgrade
|
| EBITDA | -3.54 | -10.82 | -10.27 | 2.33 | 0.65 | -1.51 | Upgrade
|
| EBITDA Margin | -4.01% | -15.13% | -16.44% | 3.80% | 1.49% | -6.14% | Upgrade
|
| D&A For EBITDA | 4.04 | 2.4 | 2.02 | 1.97 | 1.97 | 1.18 | Upgrade
|
| EBIT | -7.57 | -13.22 | -12.29 | 0.36 | -1.32 | -2.69 | Upgrade
|
| EBIT Margin | -8.59% | -18.49% | -19.68% | 0.59% | -3.06% | -10.92% | Upgrade
|
| Advertising Expenses | - | - | - | - | 0.62 | 0.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.